May 17, 2020

Why Verisk Analytics is putting its healthcare division up for sale

healthcare
Verisk
Finance
Morgan Stanley
Admin
2 min
Verisk Health is attempting to change the healthcare industry by providing data services, analytics and advanced technologies.
Data analytics provider Verisk Analytics has recently hired investment firm Morgan Stanley to sell its healthcare division, Verisk Health, in a deal ant...

Data analytics provider Verisk Analytics has recently hired investment firm Morgan Stanley to sell its healthcare division, Verisk Health, in a deal anticipated to be worth between $900 million and $1.08 billion.

Verisk Analytics serves HR departments, supply chain specialists, retail businesses, commercial real estate developers and government services among others. The sale could be a very attractive for merging and acquisition (M&A) opportunities for companies looking to strengthen their footprint in healthcare data analytics. 

RELATED TOPIC: Siemens To Sell Hospital IT Business for Alleged $1.4 Billion

Meanwhile, Verisk Health is attempting to change the healthcare industry by providing data services, analytics and advanced technologies that answer some of the sector’s most complex challenges. Its population health analytics arm uses predictive science to identify opportunities for interventions as well as to judge risk levels for patients.

The company also has a payment answer arm which works on claim accuracy and fraud protection. It serves Healthcare Effectiveness Data and Information Set management, legal providers and life insurance.

The Salt Lake City-based company has a focus on reducing risk across all domains of healthcare, and also helps health plans, employers, providers and other risk-bearing entities improve its quality of healthcare delivery and cutting costs among others.

RELATED TOPIC: The rise of pharma sales and the impact on patient care

Verisk has acquired several companies since joining the healthcare sector in 2004, and some of its customers include health plans, Medicare Advantage, Managed Medicaid, employers and life insurance carriers.

In 2011, Verisk bought Medicare and Medicaid data collector Health Risk Partners LLC for $60 million before purchasing venture capital-backed MediConnect Global for $358.6 million in 2012.

This past March, Verisk announced its acquisition of a Scottish oil, gas and energy consultancy and data analysis provider Wood Mackenzie for $2.8 billion. The purchase represented the company’s surge into the energy, chemicals and mining industries.

RELATED TOPIC: 10 Things to Remember When Selling to Hospitals in 2015

In its most recent quarterly filing in July, Verisk Analytics noted that its healthcare and financial services solutions businesses led its revenue growth in the quarter. The healthcare business reported decision analytics revenues of $69 million in the three months ended June 30, as compared to $65.1 million the previous year.

Verisk is not the only large company considering divestitures of healthcare IT units. In early September, manufacturing giant 3M Co. announced it was exploring strategic alternatives for its global Health Information Systems Businesses, including spinning off, selling, or retaining and investing in the business.

Let's connect!   

Click here to read the latest edition of Healthcare Global magazine!

 

Share article

Jun 17, 2021

Dexcom: changing the lives of people with type 1 diabetes

diabetes
glucosemonitoring
type1diabetes
insulin
3 min
British actress Nina Wadia OBE tells us how her son's life has changed since using glucose monitoring system Dexcom

It is estimated that 9.3% of adults around the world are living with type 1 diabetes, which amounts to a total of 463 million people. A further 1.1 million children and adolescents under the age of 20 are living with the condition. 

Unlike the more prevalent type 2 diabetes, where the body still produces insulin and symptoms develop slowly, people with type 1 diabetes need regular insulin injections or pumps, and must monitor their sugar levels frequently. 

In recent years a number of remote glucose monitoring systems have become available that patients can use at home. These work with a sensor, usually placed under the skin, that measures glucose levels every few minutes. This information is then transmitted wirelessly to a device like a smartphone or tablet, which can then be shared with their clinician. 

British actress Nina Wadia's son Aidan, 14, has type 1 diabetes, and has been managing his condition using Dexcom, a glucose monitoring system used by patients all over the world. Here Wadia explains how Dexcom has improved their lives. 

As a parent of someone with type 1 diabetes, what is your day-to-day life like?
Being able to take a breath, think and pivot constantly without getting frustrated becomes an essential mindset because sometimes it feels like each day is determined to be different from the day before. Whatever worked yesterday is going to misfire today. 

Which areas of yours and Aidan’s life are most impacted by diabetes? 
The one thing that you have to fight hard to reclaim is spontaneity, especially when it comes to food and exercise. It’s only when this is taken do you realise how essential each one is. You can be flexible and there are no real limits, but only in the sense that a great athlete can be flexible without limits because they’ve trained super hard to be that way. So we’ve all had to become athletes when it comes to being spontaneous.

How has Dexcom helped you and Aidan? 
Dexcom has brought future science fiction to real life today. The continuous glucose monitoring system is tiny, sits discreetly on his body and gives him a ten-day breather between sensor changes, so it's goodbye finger-pricking seven times daily. 

Dexcom is totally active at a grass roots level and for Diabetes Awareness has pledged to donate £2,000 if #DexcomDiabetesStories and/or #DexcomWarriorStories is shared 200 times! I’ll be sharing more on social media and would love to hear how other families are winning their fights.

Maybe most importantly Dexcom is trying to introduce a reimbursement programme for type 1 diabetes  patients which will give greater access to modern, life changing hi-tech. I want to spread the word on the importance of accessing it through this campaign. 

If you compared your life today with how it was before Aidan was using Dexcom, what has changed? 
It's always working, which lets him take his mind off diabetes for longer stretches. It also lets me get off his back. We both receive alerts so I no longer have to pester him by asking him what his number is, and especially importantly, I don’t have to wake him at night to prick his finger if I’m worried. Dexcom gave us back our sleep!

Share article